PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e32983
Carcharhinid sharks can make up a large fraction of the top predators inhabiting tropical marine ecosystems and have declined in many regions due to intense...
PROTECTED AREAS | BAITED VIDEO | DE-NORONHA ARCHIPELAGO | CONSERVATION | FISH ASSEMBLAGES | MOVEMENT PATTERNS | HABITAT USE | MULTIDISCIPLINARY SCIENCES | POPULATIONS | COMMUNITIES | CARCHARHINUS-PEREZI | Animals | Ecosystem | Sharks | Belize | Conservation of Natural Resources | Coral Reefs | Population Dynamics | Coral reefs and islands | Coral reef ecology | Protection and preservation | Exhibitions | Fishing | Natural areas | Marine parks and reserves | Protected areas | Fidelity | Marine ecology | Underwater | Acoustics | Marine conservation | National parks | Predators | Ecological monitoring | Physiology | Acoustic surveying | Coral reefs | Reserves | Fisheries | Commercial fishing | Abundance | Marine biology | Environmental factors | Fishing zones | Atmospheric sciences | Pressure | Biological diversity | Prey | Studies | Hypotheses | Fish populations | Relative abundance | Marine ecosystems | Adults | Environmental monitoring | Underwater acoustics | Remote monitoring
PROTECTED AREAS | BAITED VIDEO | DE-NORONHA ARCHIPELAGO | CONSERVATION | FISH ASSEMBLAGES | MOVEMENT PATTERNS | HABITAT USE | MULTIDISCIPLINARY SCIENCES | POPULATIONS | COMMUNITIES | CARCHARHINUS-PEREZI | Animals | Ecosystem | Sharks | Belize | Conservation of Natural Resources | Coral Reefs | Population Dynamics | Coral reefs and islands | Coral reef ecology | Protection and preservation | Exhibitions | Fishing | Natural areas | Marine parks and reserves | Protected areas | Fidelity | Marine ecology | Underwater | Acoustics | Marine conservation | National parks | Predators | Ecological monitoring | Physiology | Acoustic surveying | Coral reefs | Reserves | Fisheries | Commercial fishing | Abundance | Marine biology | Environmental factors | Fishing zones | Atmospheric sciences | Pressure | Biological diversity | Prey | Studies | Hypotheses | Fish populations | Relative abundance | Marine ecosystems | Adults | Environmental monitoring | Underwater acoustics | Remote monitoring
Journal Article
NeuroImage, ISSN 1053-8119, 01/2016, Volume 124, Issue Pt B, pp. 1120 - 1124
The Parkinson's Disease Biomarkers Program (PDBP) is a multi-site study designed to identify Parkinson's disease (PD) biomarkers that can be used to improve...
DIAGNOSIS | FREE-WATER | CONSENSUS STATEMENT | SUBSTANTIA-NIGRA | NEUROSCIENCES | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Parkinson Disease - pathology | Prognosis | Humans | Parkinson Disease - psychology | Disease Progression | Essential Tremor - physiopathology | Image Processing, Computer-Assisted | Biomarkers | Brain - pathology | Parkinson Disease - diagnosis | Internet | Databases, Factual | Neuroimaging - standards | Tremor | Biological markers | Diagnostic imaging | Medicine, Experimental | Medical research | Information management | Neuroimaging | Basal ganglia | Parkinson's disease | Medical imaging | Neurodegenerative diseases | Parkinsons disease | Cognitive ability | Clinical trials | Central nervous system diseases | Cerebrospinal fluid | Studies | Consortia | Researchers | Collaboration | Quality | Behavior | Movement disorders
DIAGNOSIS | FREE-WATER | CONSENSUS STATEMENT | SUBSTANTIA-NIGRA | NEUROSCIENCES | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Parkinson Disease - pathology | Prognosis | Humans | Parkinson Disease - psychology | Disease Progression | Essential Tremor - physiopathology | Image Processing, Computer-Assisted | Biomarkers | Brain - pathology | Parkinson Disease - diagnosis | Internet | Databases, Factual | Neuroimaging - standards | Tremor | Biological markers | Diagnostic imaging | Medicine, Experimental | Medical research | Information management | Neuroimaging | Basal ganglia | Parkinson's disease | Medical imaging | Neurodegenerative diseases | Parkinsons disease | Cognitive ability | Clinical trials | Central nervous system diseases | Cerebrospinal fluid | Studies | Consortia | Researchers | Collaboration | Quality | Behavior | Movement disorders
Journal Article
Conservation Biology, ISSN 0888-8892, 04/2018, Volume 32, Issue 2, pp. 376 - 389
The shark fin trade is a major driver of shark exploitation in fisheries all over the world, most of which are not managed on a species‐specific basis....
wildlife trade | manejo de pesquerías | conservation | forensics | mercado de vida silvestre | Asia | DNA | ADN | fisheries management | ciencias forenses | conservación | NUMBER | RICHNESS | ENVIRONMENTAL SCIENCES | FISHERIES | PRODUCTS | ESTIMATORS | ECOLOGY | BIODIVERSITY CONSERVATION | Surveys | Wildlife conservation | Forensic sciences | Sharks | Fisheries management | Check lists | Probability theory | Species extinction | Markets | Fisheries | Fins | Species composition | Identification | Vulnerability | Surveying | Biodiversity | Rare species | Exploitation | Vulnerable species | Species diversity | Trade | Threatened species | Marine fish | Bayesian analysis
wildlife trade | manejo de pesquerías | conservation | forensics | mercado de vida silvestre | Asia | DNA | ADN | fisheries management | ciencias forenses | conservación | NUMBER | RICHNESS | ENVIRONMENTAL SCIENCES | FISHERIES | PRODUCTS | ESTIMATORS | ECOLOGY | BIODIVERSITY CONSERVATION | Surveys | Wildlife conservation | Forensic sciences | Sharks | Fisheries management | Check lists | Probability theory | Species extinction | Markets | Fisheries | Fins | Species composition | Identification | Vulnerability | Surveying | Biodiversity | Rare species | Exploitation | Vulnerable species | Species diversity | Trade | Threatened species | Marine fish | Bayesian analysis
Journal Article
Movement Disorders, ISSN 0885-3185, 06/2016, Volume 31, Issue 6, pp. 915 - 923
Background Neuroprotection for Parkinson's disease (PD) remains elusive. Biomarkers hold the promise of removing roadblocks to therapy development. The...
Parkinsonism | biofluids | data management | disease‐modifying strategies | Biofluids | Data management | Disease-modifying strategies | RISK | disease-modifying strategies | CLINICAL NEUROLOGY | National Institute of Neurological Disorders and Stroke (U.S.) | Program Development | Multicenter Studies as Topic | United States | Humans | Biomarkers | Parkinson Disease - diagnosis | Parkinson's disease | Information management | Tremor | Biological markers
Parkinsonism | biofluids | data management | disease‐modifying strategies | Biofluids | Data management | Disease-modifying strategies | RISK | disease-modifying strategies | CLINICAL NEUROLOGY | National Institute of Neurological Disorders and Stroke (U.S.) | Program Development | Multicenter Studies as Topic | United States | Humans | Biomarkers | Parkinson Disease - diagnosis | Parkinson's disease | Information management | Tremor | Biological markers
Journal Article
NeuroImage, ISSN 1053-8119, 1/2016, Volume 124, Issue 0, pp. 1120 - 1124
The Parkinson’s Disease Biomarkers Program (PDBP) is a multi-site study designed to identify Parkinson’s Disease (PD) biomarkers that can be used to improve...
Journal Article
Clinical Pediatrics, ISSN 0009-9228, 1/2017, Volume 56, Issue 1, pp. 5 - 12
Given the genuine gaps in the availability of clinical sleep services for children, sleep coaching as a field has emerged and appears to be significantly...
sleep | night wakings | DISORDERS | PEDIATRICS | infant | bedtime | child | Families & family life | Sleep disorders | Pediatrics
sleep | night wakings | DISORDERS | PEDIATRICS | infant | bedtime | child | Families & family life | Sleep disorders | Pediatrics
Journal Article
Conservation Biology, ISSN 0888-8892, 04/2018, Volume 32, Issue 2, pp. 376 - 389
Journal Article
Pediatric Clinics of North America, ISSN 0031-3955, 06/2011, Volume 58, Issue 3, pp. 543 - 554
Sleep is a vital physiologic function. Asking parents about their children's sleep should be part of every routine physical examination. Evaluating infants...
Pediatrics | Sleep disorders | Sleep | Children | Primary care | INFANT-DEATH-SYNDROME | ENURESIS | Humans | Sleep Wake Disorders - diagnosis | Surveys and Questionnaires | Primary Health Care | Sleep - physiology | Sleep Wake Disorders - physiopathology | Child | Stress, Psychological - etiology
Pediatrics | Sleep disorders | Sleep | Children | Primary care | INFANT-DEATH-SYNDROME | ENURESIS | Humans | Sleep Wake Disorders - diagnosis | Surveys and Questionnaires | Primary Health Care | Sleep - physiology | Sleep Wake Disorders - physiopathology | Child | Stress, Psychological - etiology
Journal Article
Science, ISSN 0036-8075, 2/2013, Volume 339, Issue 6121, pp. 757 - 757
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2015, Volume 14, Issue 8, pp. 795 - 803
Summary Background A systematic assessment of potential disease-modifying compounds for Parkinson's disease concluded that pioglitazone could hold promise for...
Neurology | NET-PD EXPERIENCE | CLINICAL-TRIAL | FUTILITY | ALZHEIMERS-DISEASE | ACTIVATED-RECEPTOR-GAMMA | VALIDATION | RATING-SCALE | NEUROPROTECTION | PROGRESSION | CLINICAL NEUROLOGY | HEALTH-EXPLORATORY-TRIALS | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Thiazolidinediones - administration & dosage | Thiazolidinediones - adverse effects | Neuroprotective Agents - pharmacology | Selegiline - administration & dosage | Medical Futility | Female | Aged | Indans - administration & dosage | Neuroprotective Agents - adverse effects | Drug Therapy, Combination | Neuroprotective Agents - administration & dosage | Thiazolidinediones - pharmacology | Clinical trials | Medicine, Experimental | Medical research | Parkinson's disease | Rasagiline | Analysis | Studies | Activities of daily living | Consent | Parkinsons disease | FDA approval | Diabetes | Pharmaceutical industry | Geriatrics
Neurology | NET-PD EXPERIENCE | CLINICAL-TRIAL | FUTILITY | ALZHEIMERS-DISEASE | ACTIVATED-RECEPTOR-GAMMA | VALIDATION | RATING-SCALE | NEUROPROTECTION | PROGRESSION | CLINICAL NEUROLOGY | HEALTH-EXPLORATORY-TRIALS | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Thiazolidinediones - administration & dosage | Thiazolidinediones - adverse effects | Neuroprotective Agents - pharmacology | Selegiline - administration & dosage | Medical Futility | Female | Aged | Indans - administration & dosage | Neuroprotective Agents - adverse effects | Drug Therapy, Combination | Neuroprotective Agents - administration & dosage | Thiazolidinediones - pharmacology | Clinical trials | Medicine, Experimental | Medical research | Parkinson's disease | Rasagiline | Analysis | Studies | Activities of daily living | Consent | Parkinsons disease | FDA approval | Diabetes | Pharmaceutical industry | Geriatrics
Journal Article
JAMA, ISSN 0098-7484, 02/2015, Volume 313, Issue 6, pp. 584 - 593
IMPORTANCE: There are no treatments available to slow or prevent the progression of Parkinson disease, despite its global prevalence and significant health...
TESTS | MEDICINE, GENERAL & INTERNAL | QUALITY | QUESTIONNAIRE | LEVODOPA | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Antiparkinson Agents - adverse effects | Creatine - blood | Disease Progression | Antiparkinson Agents - therapeutic use | Medication Adherence | Creatine - therapeutic use | Female | Aged | Creatine - adverse effects | Drug Therapy, Combination | Care and treatment | Usage | Parkinson's disease | Clinical trials | Dosage and administration | Creatine | Patients | Health aspects | Risk factors | Medical research | Parkinsons disease
TESTS | MEDICINE, GENERAL & INTERNAL | QUALITY | QUESTIONNAIRE | LEVODOPA | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Antiparkinson Agents - adverse effects | Creatine - blood | Disease Progression | Antiparkinson Agents - therapeutic use | Medication Adherence | Creatine - therapeutic use | Female | Aged | Creatine - adverse effects | Drug Therapy, Combination | Care and treatment | Usage | Parkinson's disease | Clinical trials | Dosage and administration | Creatine | Patients | Health aspects | Risk factors | Medical research | Parkinsons disease
Journal Article
Movement Disorders, ISSN 0885-3185, 06/2007, Volume 22, Issue 8, pp. 1061 - 1068
There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the...
Parkinson's | diagnosis | psychosis | Psychosis | Diagnosis | RISK-FACTORS | DEMENTIA | VISUAL HALLUCINATIONS | DRUG-INDUCED PSYCHOSIS | FOLLOW-UP | SYMPTOMS | PREVALENCE | CLINICAL NEUROLOGY | LEVODOPA | AUDITORY HALLUCINATIONS | LEWY BODIES | Severity of Illness Index | Psychotic Disorders - diagnosis | Diagnosis, Differential | Prevalence | Publishing - statistics & numerical data | United States | Humans | Psychotic Disorders - psychology | Psychotic Disorders - epidemiology | Consensus | National Institute of Mental Health (U.S.) | Education | Parkinson Disease - epidemiology
Parkinson's | diagnosis | psychosis | Psychosis | Diagnosis | RISK-FACTORS | DEMENTIA | VISUAL HALLUCINATIONS | DRUG-INDUCED PSYCHOSIS | FOLLOW-UP | SYMPTOMS | PREVALENCE | CLINICAL NEUROLOGY | LEVODOPA | AUDITORY HALLUCINATIONS | LEWY BODIES | Severity of Illness Index | Psychotic Disorders - diagnosis | Diagnosis, Differential | Prevalence | Publishing - statistics & numerical data | United States | Humans | Psychotic Disorders - psychology | Psychotic Disorders - epidemiology | Consensus | National Institute of Mental Health (U.S.) | Education | Parkinson Disease - epidemiology
Journal Article
Clinical Pediatrics, ISSN 0009-9228, 01/2017, Volume 56, Issue 1, pp. 5 - 12
Journal Article
Marine Ecology Progress Series, ISSN 0171-8630, 08/2017, Volume 576, pp. 1 - 10
Marine reserves, areas protected from exploitative anthropogenic processes, are being widely implemented to conserve biodiversity and initiate species...
Longline | Marine protected area | Fisheries management | Caribbean | Elasmobranch | Coral reef conservation | PROTECTED AREAS | MOVEMENTS | ATLANTIC | PATTERNS | CARCHARHINUS-PEREZI | RECOVERY | DE-NORONHA ARCHIPELAGO | CONSERVATION | MARINE & FRESHWATER BIOLOGY | OCEANOGRAPHY | CONSEQUENCES | ECOLOGY | DECLINES
Longline | Marine protected area | Fisheries management | Caribbean | Elasmobranch | Coral reef conservation | PROTECTED AREAS | MOVEMENTS | ATLANTIC | PATTERNS | CARCHARHINUS-PEREZI | RECOVERY | DE-NORONHA ARCHIPELAGO | CONSERVATION | MARINE & FRESHWATER BIOLOGY | OCEANOGRAPHY | CONSEQUENCES | ECOLOGY | DECLINES
Journal Article
Neurology, ISSN 0028-3878, 08/2014, Volume 83, Issue 9, pp. 851 - 860
The National Alzheimerʼs Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimerʼs Disease that is updated annually. In the Plan,...
DIAGNOSTIC GUIDELINES | NATIONAL INSTITUTE | MILD COGNITIVE IMPAIRMENT | CLINICAL NEUROLOGY | ASSOCIATION WORKGROUPS | Research | Alzheimer Disease | United States | Humans | Dementia | Views & Reviews
DIAGNOSTIC GUIDELINES | NATIONAL INSTITUTE | MILD COGNITIVE IMPAIRMENT | CLINICAL NEUROLOGY | ASSOCIATION WORKGROUPS | Research | Alzheimer Disease | United States | Humans | Dementia | Views & Reviews
Journal Article
Movement Disorders, ISSN 0885-3185, 02/2006, Volume 21, Issue 2, pp. 148 - 158
Mood disorders are the most common psychiatric problem associated with Parkinson's disease (PD), and have a negative impact on disability and quality of life....
diagnosis | Parkinson's disease | depression | mood disorders | affective symptoms | Mood disorders | Depression | Affective symptoms | Diagnosis | RISK-FACTORS | DEMENTIA | MAJOR DEPRESSION | PREVALENCE | CLINICAL NEUROLOGY | COMORBIDITY | MOOD | NONMOTOR SYMPTOMS | DISABILITY | DISORDER | QUALITY-OF-LIFE | Diagnosis, Differential | Diagnostic and Statistical Manual of Mental Disorders | Comorbidity | Humans | Depressive Disorder - diagnosis | Parkinson Disease - diagnosis | Depressive Disorder - psychology | Parkinson Disease - psychology
diagnosis | Parkinson's disease | depression | mood disorders | affective symptoms | Mood disorders | Depression | Affective symptoms | Diagnosis | RISK-FACTORS | DEMENTIA | MAJOR DEPRESSION | PREVALENCE | CLINICAL NEUROLOGY | COMORBIDITY | MOOD | NONMOTOR SYMPTOMS | DISABILITY | DISORDER | QUALITY-OF-LIFE | Diagnosis, Differential | Diagnostic and Statistical Manual of Mental Disorders | Comorbidity | Humans | Depressive Disorder - diagnosis | Parkinson Disease - diagnosis | Depressive Disorder - psychology | Parkinson Disease - psychology
Journal Article